United Therapeutics | UTHR - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Amarin USD 18.8M 29.36M 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Baxter International USD 1.03B 52M 2026-06
Bayer EUR 6.39B 192M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Emergent BioSolutions USD 112.2M 500K 2023-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Insmed USD 74.55M 1.18M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.22B 1.24B 2026-06
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Moderna USD 167M 6M 2026-06
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
United Therapeutics USD 497.8M 500K 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06